NCT06088498

App for Reducing Cravings to Smoke

Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation
H. Lee Moffitt Cancer Center and Research Institute·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Smoking
Drug/Device/Intervention
Updating Existing Smartphone App
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
H. Lee Moffitt Cancer Center and Research Institute
Location
Tampa, United States of America
Timeline & enrollment
Phase
N/A
Start date
Oct 09, 2023
End date
Dec 31, 2025
Enrollment
2082 participants
Primary outcome

System Usability Scale (Aim 1),Tobacco Abstinence (Aim 2)

Summary

The overall goal of the study is to assess the efficacy of using cue exposure delivered via a
 smartphone application as an adjunct to Tobacco Quitline treatment to improve smoking
 abstinence.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06088498
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06088498 through Pure Global AI's free database. This phase not specified trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute and is currently Recruiting. The study focuses on Smoking. Target enrollment is 2082 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.